547 related articles for article (PubMed ID: 32460858)
1. Quantitative proteomic analysis of Rett iPSC-derived neuronal progenitors.
Varderidou-Minasian S; Hinz L; Hagemans D; Posthuma D; Altelaar M; Heine VM
Mol Autism; 2020 May; 11(1):38. PubMed ID: 32460858
[TBL] [Abstract][Full Text] [Related]
2. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
[TBL] [Abstract][Full Text] [Related]
3. CREB Signaling Is Involved in Rett Syndrome Pathogenesis.
Bu Q; Wang A; Hamzah H; Waldman A; Jiang K; Dong Q; Li R; Kim J; Turner D; Chang Q
J Neurosci; 2017 Mar; 37(13):3671-3685. PubMed ID: 28270572
[TBL] [Abstract][Full Text] [Related]
4. Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model.
Ananiev G; Williams EC; Li H; Chang Q
PLoS One; 2011; 6(9):e25255. PubMed ID: 21966470
[TBL] [Abstract][Full Text] [Related]
5. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
6. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.
Mellios N; Feldman DA; Sheridan SD; Ip JPK; Kwok S; Amoah SK; Rosen B; Rodriguez BA; Crawford B; Swaminathan R; Chou S; Li Y; Ziats M; Ernst C; Jaenisch R; Haggarty SJ; Sur M
Mol Psychiatry; 2018 Apr; 23(4):1051-1065. PubMed ID: 28439102
[TBL] [Abstract][Full Text] [Related]
7. Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells.
Andoh-Noda T; Inouye MO; Miyake K; Kubota T; Okano H; Akamatsu W
CNS Neurol Disord Drug Targets; 2016; 15(5):544-50. PubMed ID: 27071793
[TBL] [Abstract][Full Text] [Related]
8. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
Mol Autism; 2017; 8():56. PubMed ID: 29090078
[TBL] [Abstract][Full Text] [Related]
9. Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons.
Williams EC; Zhong X; Mohamed A; Li R; Liu Y; Dong Q; Ananiev GE; Mok JC; Lin BR; Lu J; Chiao C; Cherney R; Li H; Zhang SC; Chang Q
Hum Mol Genet; 2014 Jun; 23(11):2968-80. PubMed ID: 24419315
[TBL] [Abstract][Full Text] [Related]
10. Investigation of Rett syndrome using pluripotent stem cells.
Dajani R; Koo SE; Sullivan GJ; Park IH
J Cell Biochem; 2013 Nov; 114(11):2446-53. PubMed ID: 23744605
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.
Andoh-Noda T; Akamatsu W; Miyake K; Matsumoto T; Yamaguchi R; Sanosaka T; Okada Y; Kobayashi T; Ohyama M; Nakashima K; Kurosawa H; Kubota T; Okano H
Mol Brain; 2015 May; 8():31. PubMed ID: 26012557
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analyses reveal misregulation of LIN28 expression and delayed timing of glial differentiation in human iPS cells with MECP2 loss-of-function.
Kim JJ; Savas JN; Miller MT; Hu X; Carromeu C; Lavallée-Adam M; Freitas BCG; Muotri AR; Yates JR; Ghosh A
PLoS One; 2019; 14(2):e0212553. PubMed ID: 30789962
[TBL] [Abstract][Full Text] [Related]
13. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome.
Kim KY; Hysolli E; Park IH
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14169-74. PubMed ID: 21807996
[TBL] [Abstract][Full Text] [Related]
14. Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach.
Pascual-Alonso A; Xiol C; Smirnov D; Kopajtich R; Prokisch H; Armstrong J
Hum Genomics; 2023 Sep; 17(1):85. PubMed ID: 37710353
[TBL] [Abstract][Full Text] [Related]
15. Isogenic Human-Induced Pluripotent Stem-Cell-Derived Cardiomyocytes Reveal Activation of Wnt Signaling Pathways Underlying Intrinsic Cardiac Abnormalities in Rett Syndrome.
Ng KM; Ding Q; Tse YL; Chou OH; Lai WH; Au KW; Lau YM; Ji Y; Siu CW; Tang CS; Colman A; Tsang SY; Tse HF
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555252
[TBL] [Abstract][Full Text] [Related]
16. JNK signaling provides a novel therapeutic target for Rett syndrome.
Musi CA; Castaldo AM; Valsecchi AE; Cimini S; Morello N; Pizzo R; Renieri A; Meloni I; Bonati M; Giustetto M; Borsello T
BMC Biol; 2021 Dec; 19(1):256. PubMed ID: 34911542
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2).
Tanaka Y; Kim KY; Zhong M; Pan X; Weissman SM; Park IH
Hum Mol Genet; 2014 Feb; 23(4):1045-55. PubMed ID: 24129406
[TBL] [Abstract][Full Text] [Related]
18. Modeling Rett Syndrome with Human Pluripotent Stem Cells: Mechanistic Outcomes and Future Clinical Perspectives.
Gomes AR; Fernandes TG; Cabral JMS; Diogo MM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916879
[TBL] [Abstract][Full Text] [Related]
19. Brain protein changes in Mecp2 mouse mutant models: Effects on disease progression of Mecp2 brain specific gene reactivation.
Cortelazzo A; De Felice C; Guy J; Timperio AM; Zolla L; Guerranti R; Leoncini S; Signorini C; Durand T; Hayek J
J Proteomics; 2020 Jan; 210():103537. PubMed ID: 31629059
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: new perspective for Rett syndrome.
Squillaro T; Alessio N; Cipollaro M; Melone MA; Hayek G; Renieri A; Giordano A; Galderisi U
Mol Biol Cell; 2012 Apr; 23(8):1435-45. PubMed ID: 22357617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
